ICCBBA (www.isbt128.org/about-iccbba) broadly welcomes the proposed framework for Blood, Tissues and Cells as an advance on the current directives. We wish to highlight the following: A prerequisite for safety through biovigilance is an ability to effectively trace a product from the donation event to its transfusion or transplantation into another person.
ICCBBA
NGO · United States · EU Transparency Register 248042825272-17
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 964 non-governmental organisations on this site, they rank #594 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- Worldwide Network for Blood & Marrow Transplantation (WBMT)
- ISBT
- HL7 International
- American National Standards Institute (ANSI)
- WHO - Non-State Actor in Official Relations with WHO
- Joint Initiative Council for Global Health Informatics Standardization (JIC)
- Standards Coordinating Body (SCB)
- Alliance for Regenerative Medicine (ARM) under Foundations
- Associations
- & Patient Advocates
- Current collaborations are listed at https://www.isbt128.org/collaborations.
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Non-governmental organisations
- Registered as
- International Council for Commonality in Blood Banking Automation (ICCBBA)
- Head office
- Redlands, United states
- EU office
- Barcelona
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track ICCBBA in PolicySpeak: request access →
Work at ICCBBA? so we know who speaks for it.
Their record over time
ICCBBA filed 2 positions between 14 Dec 2020 and 8 Sept 2022, across 1 of the 583 legislative files tracked here, attaching a full position paper 2 times.
What they argued
A revision of the BTC legislation is to be welcomed. In particular, a consistent approach to the unique identification of all products derived from a human donor is essential to ensure rapid and effective recall and follow-up.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put ICCBBA next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from ICCBBA’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.